Agenparl

zeposia

Agenparl English Diritto & Giustizia Salute Social Network

HUMAN MEDICINES EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR): ZEPOSIA, OZANIMOD, MULTIPLE SCLEROSIS, RELAPSING-REMITTING, DATE OF AUTHORISATION: 20/05/2020, STATUS: AUTHORISED

Redazione
(AGENPARL) – LONDON (UNITED KINGDOM), mar 27 ottobre 2020 Zeposia is a medicine used to treat adults with relapsing-remitting multiple sclerosis (RRMS), where the patient has flare-ups (relapses) followed by periods with milder or no symptoms (remission). It is used in patients with active disease, which means that patients have......

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More